Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

β-Amyloid Peptide Variants in Brains and Cerebrospinal Fluid from Amyloid Precursor Protein (APP) Transgenic Mice

(2011) Heinke Schieb et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Window into the Heterogeneity of Human Cerebrospinal Fluid AβPeptides

(2011) Roberta Ghidoni et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Soluble Aβ oligomer production and toxicity

(2011) Megan E. Larson et al.   JOURNAL OF NEUROCHEMISTRY

Structural Design, Solid-Phase Synthesis and Activity of Membrane-Anchored β-Secretase Inhibitors on Aβ Generation from Wild-Type and Swedish-Mutant APP

(2010) Heinke Schieb et al.   CHEMISTRY-A EUROPEAN JOURNAL

Cerebrospinal Fluid Tau, p-Tau 181 and Amyloid-β38/40/42 in Frontotemporal Dementias and Primary Progressive Aphasias

(2010) Mirko Bibl et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Optimization protocol for amyloid-β peptides detection in human cerebrospinal fluid using SELDI TOF MS

(2010) Valentina Albertini et al.   Proteomics Clinical Applications

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

(2009) Volker Welge et al.   JOURNAL OF NEURAL TRANSMISSION

Aminopeptidase A contributes to the N-terminal truncation of amyloid β-peptide

(2009) Jean Sevalle et al.   JOURNAL OF NEUROCHEMISTRY

Identification of Novel APP/Aβ Isoforms in Human Cerebrospinal Fluid

(2009) Erik Portelius et al.   Neurodegenerative Diseases

CSF amyloid-β 1-38 and 1-42 in FTD and AD: Biomarker performance critically depends on the detergent accessible fraction

(2008) Mirko Bibl et al.   Proteomics Clinical Applications